Yifan Pang is an Oncology physician affiliated with Levine Cancer Institute. OpenAlex indexes 84 publications with 1,021 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1021 Morehead Medical Dr
Ste A
Charlotte, NC 282042990
Telephone
980-442-2000Provider last certified this registry record 4 Jun 2026.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Syndax Pharmaceuticals, Inc.Program year20254 payments
- Autolus IncProgram year20251 payment
- ImmunoGen, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
27.3%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor27.3%Acyclovir100%Part D≥40 patientsAnti-infectives
22.2%Short-acting sulfonamides8.9%Sulfamethoxazole-Trimethoprim100%Part D≥13 patientsFluoroquinolone Antibacterial7.5%Levofloxacin100%Part D≥17 patients+ 1 more class in this area
Metabolism & gastrointestinal
22%Serotonin-3 Receptor Antagonist8.7%Ondansetron Hcl100%Part D≥21 patientsCorticosteroid8.7%Prednisone100%Part D≥16 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Regional economic development level assessment based on K-means clustering algorithm
Procedia Computer Science
2025 - Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma
Biology of Blood and Marrow Transplantation
2024 - Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma
Frontiers in Oncology
2024 - A multimodal data sensing and feature learning-based self-adaptive hybrid approach for machining quality prediction
Advanced Engineering Informatics
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Voorhees, MD
Levine Cancer Institute
Edward Copelan, MD
Levine Cancer Institute
Nilanjan Ghosh, MD
Levine Cancer Institute
Antoinette Tan, MD
Levine Cancer Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”